Enanta Pharmaceuticals Inc. (ENTA)
NASDAQ · Healthcare
Enanta Pharmaceuticals Inc. Operating Income 2020–2025
Enanta Pharmaceuticals Inc. annual/quarterly operating income history and growth rate from 2020 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Enanta Pharmaceuticals Inc. operating income for the quarter ending March 31, 2026 was -11.9 M.
- Enanta Pharmaceuticals Inc. operating income for the twelve months ending March 31, 2026 was -60.4 M.
- Enanta Pharmaceuticals Inc. annual operating income for 2025 was -85.3 M, a 29.86% decrease from 2024.
- Enanta Pharmaceuticals Inc. annual operating income for 2024 was -121.7 M, a 11.31% decrease from 2023.
- Enanta Pharmaceuticals Inc. annual operating income for 2023 was -137.2 M, a 10.79% increase from 2022.
- Enanta Pharmaceuticals Inc. annual operating income for 2022 was -123.8 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Enanta Pharmaceuticals Inc. Operating Income — FAQ
Enanta Pharmaceuticals Inc. (ENTA) operating income over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
What is Enanta Pharmaceuticals Inc.'s operating income?
Enanta Pharmaceuticals Inc. (ENTA) reported operating income of -$85M for fiscal 2025.
Where can I see ENTA's operating income history?
The chart and table above show Enanta Pharmaceuticals Inc.'s operating income by year and by quarter, including the growth rate.